Site distribution of gastrointestinal carcinoids differs between races.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Clinicopathological characteristics of rectal multiple neuroendocrine neoplasms and literature review.BMC surgery · 2023
   Review
2. Comparison between endoscopic mucosal resection with a cap and endoscopic submucosal dissection for rectal neuroendocrine tumors.BMC surgery · 2022
   Article
3. Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines.Molecular and clinical oncology · 2017
   Article
4. Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.Journal of gastroenterology · 2016
   Article
5. Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix.Pathology oncology research : POR · 2011
   Article
6. Treatment of colorectal carcinoids: A new paradigm.World journal of gastrointestinal surgery · 2010
   Article
7. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years.Gut · 2007
   Article

Corrections and comments

• Comment on
  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.2005

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as